Rising prevalence of colorectal cancer and other endoscopy-related diseases to boost the growth of endoscope reprocessing device market.
Market Overview:
Endoscope
reprocessing devices are those which are made to kill the organisms in the
reusable endoscopes using high disinfectants or liquid chemical solutions to
expose the exterior surfaces and the interior channels. Manual cleaning,
sterilization, documentation, leak testing and pre –cleaning are some of the
steps performed in endoscopy reprocessing.
Competitive Landscape:
The major players operating the endoscope
reprocessing device market are STERIS Plc., Cilag GmbH International, Steelco
S.p.A., Minntech Corp PENTAX Medical, Medivators Inc., Wassenburg Medical B.V.,
Soluscope, ENDO-TECHNIK W.Griesat GmbH, Johnson & Johnson and Getinge AB.
Key Market Drivers:
Rising prevalence of colorectal cancer and other
endoscopy-related diseases are anticipated to augment the growth of the global
endoscope reprocessing device market. For instance, as per the American Cancer
Society, nearly 97,220 people are diagnosed with colorectal cancer and 43,030
rectal cancer by the end of 2018.
Furthermore, increasing cardiovascular diseases
which are treated with using ERs is anticipated to boost the growth of the
global endoscope reprocessing device market. For instance, as per OECD, 45,307
people have undergone the coronary heart bypass surgery/operation in Germany as
of 2018.
Covid-19 Impact
Analysis:
During the pandemic, along with the sterilization
the ERs have also increased as the reprocessors have been a crucial part for
the endoscopy surgeries which led to the growth of the global endoscope
reprocessing device market.
Key Takeaways:
The
global endoscope
reprocessing device market is expected to exhibit a CAGR of XX % during the
forecast period due to frequent approvals, quick launches of products. For
instance, in April 2019, Advanced Sterilization Products gained US. FDA,
launched for the ASP AEROFLEX automated endoscopes reprocessors.
Among
Regions North America, Asia Pacific and Europe are anticipated to witness
robust growth in the global endoscope reprocessing device market due to
increasing prevalence of diseases, frequent approvals. As per the Globocan,
3,244 people suffer from stomach cancer in Canada and 5,139 people suffer from pancreatic
cancer.
Comments
Post a Comment